John Koconis
Net worth: - $ as of 31/03/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Joe Lucchese | M | 57 |
Timber Pharmaceuticals LLC
 Timber Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Timber Pharmaceuticals LLC engages in the provision of biopharmaceutical services. It offers congenital ichthyosis, tuberous sclerosis complex, and localized scleroderma. The company was founded in 2019 and is headquartered in Woodcliff Lake, NJ. | 4 years |
| Jeffrey Aronin | M | 56 |
Castle Creek Biosciences, Inc.
 Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | 6 years |
| David Cohen | M | 59 | 4 years | |
| Lubor Gaal | M | 56 | 4 years | |
| Antonio Gracias | M | 53 |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | 6 years |
| Jannie Kogsbøll | M | - |
Leo Pharma, Inc.
 Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | 26 years |
| Karin Attermann | F | - |
Leo Pharma, Inc.
Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | 16 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Zachary Rome | M | 40 | 2 years | |
| John M. Maslowski | M | 49 |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | 5 years |
| Gregory Wujek | M | 62 |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | 3 years |
| William J. Bettman | M | - |
Loyola University of Chicago
| 3 years |
| Michael T. Stocum | M | 58 | - | |
| Amir Tavakkol | M | 69 |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | 3 years |
| Walt Liptak | M | - |
Loyola University of Chicago
| 6 years |
| Paul Wesley Carlson | M | - |
Loyola University of Chicago
| 5 years |
| Gregory Licholai | M | 59 |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | 2 years |
| Linda A. Broenniman | F | 67 | - | |
| Michelle M. Hermann | F | - |
Loyola University of Chicago
| 2 years |
| Ali Seyedroudbari | M | - |
Leo Pharma, Inc.
Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | - |
| Michael Panzara | M | 57 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 7 years |
| Thomas Hinterberger | M | - |
Loyola University of Chicago
| 2 years |
| Greg Paris | M | 55 |
Loyola University of Chicago
| 4 years |
| Michael O'Connor | M | - |
Loyola University of Chicago
| 3 years |
| Todd Ricketts | M | 54 |
Loyola University of Chicago
| 4 years |
| Regina Donohue | F | - |
Leo Pharma, Inc.
Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | - |
| Gary L. Laborde | M | - |
Loyola University of Chicago
| 3 years |
| Robert Drobny | M | - |
Loyola University of Chicago
| 2 years |
| Kirsten Gebert | F | - |
Leo Pharma, Inc.
Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | - |
| David Domzalski | M | 58 |
Leo Pharma, Inc.
Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | 4 years |
| Mark W. Hetzler | M | - |
Loyola University of Chicago
| 3 years |
| G. Fortenberry | M | - |
Loyola University of Chicago
| 3 years |
| Jacie Fogelberg | F | - |
Loyola University of Chicago
| 2 years |
| Dhvani Shah | F | 49 |
Loyola University of Chicago
| 4 years |
| Chris Kappas | M | - |
Loyola University of Chicago
| 3 years |
| Ted Bowen | M | - |
Loyola University of Chicago
| 4 years |
| Iain Stuart | M | 51 |
Leo Pharma, Inc.
Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | 8 years |
| Abdul Saddiqui | M | - |
Loyola University of Chicago
| - |
| Janice Olson | F | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | - |
| Christopher Hwang | M | 61 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 24 years |
| Mishima Gerhart | F | - |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 2 years |
| Alan Mendelsohn | M | 62 | 3 years | |
| Yann Mazabraud | M | 51 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 1 years |
| Joana Goncalves | M | 50 |
Leo Pharma, Inc.
Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | 2 years |
| John Malito | M | - |
Quinlan School of Business
| 2 years |
| Nora Walsh | F | - |
Loyola University of Chicago
| 4 years |
| Fatma Arzu Ergene | F | - |
Loyola University of Chicago
| 2 years |
| Matthew P. Kowalsky | M | 52 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 1 years |
| David Ford | M | 56 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 1 years |
| Charisse Brock | F | 62 |
Loyola University of Chicago
| 2 years |
| Christian Tybring-Gjedde | M | 60 |
Loyola University of Chicago
| 4 years |
| Kenneth Fincher | M | 58 |
Quinlan School of Business
| 2 years |
| Irina Antonijevic | M | 59 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | 5 years |
| Amy Weber | F | - |
Loyola University of Chicago
| 4 years |
| Matthew Massick | M | - |
Loyola University of Chicago
| 4 years |
| Gerald B. Curran | M | - |
Loyola University of Chicago
| - |
| Jay Nutt | M | 61 |
Loyola University of Chicago
| 2 years |
| Pam Gracyalny | F | - |
Loyola University of Chicago
| 3 years |
| Glen Hilton | M | - |
Loyola University of Chicago
| 4 years |
| Patrick Schumann | M | - |
Loyola University of Chicago
| 2 years |
| Marty Doyle | M | - |
Loyola University of Chicago
| 2 years |
| Terry Herr | M | - |
Loyola University of Chicago
| 4 years |
| Joe W. Cornell | M | - |
Loyola University of Chicago
| 2 years |
| David Konrad | M | - |
Loyola University of Chicago
| 2 years |
| Tasso Coin | M | 53 |
Loyola University of Chicago
| 4 years |
| Angela Charlene Williams | F | - |
Loyola University of Chicago
| 4 years |
| Ned Paul Zachar | M | - |
Loyola University of Chicago
| 2 years |
| Kevin Gordon Grant | M | - |
Loyola University of Chicago
| 2 years |
| Robert J. Wild | M | - |
Loyola University of Chicago
| 3 years |
| Paul Anthony Rokosz | M | - |
Loyola University of Chicago
| 4 years |
| Mary E. Bilbrey | F | 60 |
Loyola University of Chicago
| 3 years |
| Christine Cantor | F | - |
Loyola University of Chicago
| 2 years |
| Raymond C. Anderson | M | 58 |
Loyola University of Chicago
| 3 years |
| Brown Stephen | M | - |
Quinlan School of Business
| 2 years |
| Monica B. Haab | F | 57 |
Loyola University of Chicago
| 3 years |
| Kenneth R. Weigand | M | 67 |
Loyola University of Chicago
| 2 years |
| William Edward Rancic | M | 52 |
Loyola University of Chicago
| 4 years |
| Kimberley Elting | F | 59 |
Loyola University of Chicago
| 3 years |
| Joseph J. Dobrzynski | M | - |
Loyola University of Chicago
| 4 years |
| Gregory R. Noe | M | - |
Loyola University of Chicago
| 3 years |
| Robert Sherman Tynes | M | 61 |
Loyola University of Chicago
| 2 years |
| Jess Jankowski | M | 59 |
Loyola University of Chicago
| 2 years |
| Mary Pat Burke | F | - |
Loyola University of Chicago
| 1 years |
| Bowen Campbell | M | - |
Loyola University of Chicago
| 2 years |
| Jean Replicon | M | - |
Loyola University of Chicago
| 3 years |
| Glenn D. Garbowicz | M | - |
Loyola University of Chicago
| 2 years |
| William J. Doyle | M | 60 |
Loyola University of Chicago
| 2 years |
| Sara P. Gloss | F | - |
Loyola University of Chicago
| 4 years |
| Duncan A. Simpson | M | - |
Loyola University of Chicago
| 3 years |
| Brendan Anderson | M | - |
Loyola University of Chicago
| 2 years |
| Michael Derby | M | 51 | 2 years | |
| Donald F. Cass | M | 57 |
Loyola University of Chicago
| 4 years |
| D. Mark McMillan | M | - |
Loyola University of Chicago
| 3 years |
| Robert E. Kent | M | - |
Loyola University of Chicago
| 3 years |
| Simos Simeonidis | M | 54 |
Loyola University of Chicago
| 4 years |
| Scott C. Zimmerman | M | - |
Loyola University of Chicago
| 4 years |
| Anthony R. Donato | M | - |
Loyola University of Chicago
| 4 years |
| Lisa M. Sodeika | F | 60 |
Loyola University of Chicago
| 2 years |
| Ray Cabrera | M | 57 |
Loyola University of Chicago
| 4 years |
| Helen Yu | F | - |
Quinlan School of Business
| 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 99 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- John Koconis
- Personal Network
